PFT's

DIAGNOSTIC_TEST2 trials

Sponsors

National Cancer Institute (NCI)

Conditions

Chronic GVHDGATA2Immunodeficiency

Phase 2

Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease

CompletedNCT04294641

National Cancer Institute (NCI)Chronic GVHD

Start: 2021-05-10End: 2024-10-01Updated: 2026-01-23

Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency

Active, not recruitingNCT05907746

National Cancer Institute (NCI)GATA2, Immunodeficiency

Start: 2023-11-29End: 2028-07-31Updated: 2026-08-11